Cafepharma Today

June 2 2023 - Novartis drug helps stop breast cancer’s return in large study
Novartis drug helps stop breast cancer’s return in large study
Pfizer says antibiotic is effective against tough-to-treat infections
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Supreme Court vetoes efforts to limit anti-fraud law aimed at government contractors
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wednesday, May 31, 2023 - 11:08am
tags:
obesity, weight loss, Novo Nordisk, Eli Lilly, Pfizer, Amgen
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wednesday, May 31, 2023 - 11:06am
tags:
AbbVie, Rinvoq, Humira, systemic lupus erythematosus, lupus, clinical trials
GE HealthCare gets FDA nod for Precision DL image processing software
Medical Device Network
Wednesday, May 31, 2023 - 11:02am
tags:
GE Healthcare, FDA, deep learning, artificial intelligence, Medtech, imaging, Precision DL
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Wednesday, May 31, 2023 - 11:00am
tags:
Rain Oncology, layoffs, clinical trials, milademetan, oncology, solid tumors
eXmoor pharma raises $35m to boost cell and gene therapy production
Pharmaceutical Business Review
Wednesday, May 31, 2023 - 10:58am
tags:
eXmoor pharma, funding, cell therapy, gene therapy
This Could Be Novo Nordisk's Next Big Weight-Loss Product
Motley Fool
Wednesday, May 31, 2023 - 10:56am
tags:
Novo Nordisk, weight loss, Wegovy, oral Wegovy
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Wednesday, May 31, 2023 - 10:54am
tags:
Sanofi, MS, multiple sclerosis, clinical trials, frexalimab
Alzheimer’s disease market expected to reach $13.7bn across the 8MM by 2030
Clinical Trials Arena
Wednesday, May 31, 2023 - 10:53am
tags:
Alzheimer's disease
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wednesday, May 31, 2023 - 10:51am
tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Amylyx’s ALS drug could face rejection in Europe
BioPharma Dive
Wednesday, May 31, 2023 - 10:45am
tags:
Amylyx, ALS, EMA, Europe, Relyvrio
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Fierce Pharma
Tuesday, May 30, 2023 - 9:28pm
tags:
Alnylam Pharmaceuticals, legal, patents, vaccines, Pfizer, Moderna Therapeutics, COVID-19
Eli Lilly settles insulin suit for $13.5 million, agrees to keep price cap
Washington Post, DC
Tuesday, May 30, 2023 - 9:25pm
tags:
Eli Lilly, insulin, legal, drug pricing
Concentra finds latest acquisition attempt harder to swallow as Atea rejects 'undervalued' offer
Fierce Biotech
Tuesday, May 30, 2023 - 9:22pm
tags:
Concerta Biosciences, M&A, Atea Pharmaceuticals
Merck and Eisai tease results for renal carcinoma treatment
Clinical Trials Arena
Tuesday, May 30, 2023 - 9:18pm
tags:
Merck, Eisai, ASCO 2023, Lenvima, Keytruda, renal cell carcinoma
Sacklers win appeal that shields them from opioid lawsuits, clearing way for bankruptcy settlement
Stat
Tuesday, May 30, 2023 - 9:00pm
tags:
Purdue Pharma, Sackler family, opioids, bankruptcy, legal
Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Fierce Pharma
Tuesday, May 30, 2023 - 11:27am
tags:
Sun Pharma, M&A, Taro Pharmaceuticals, India
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Tuesday, May 30, 2023 - 10:07am
tags:
Pfizer, Novo Nordisk, clinical trials, hemophilia, marstacimab
A Biodegradable Nanocellulose ECG Patch: The Sustainable Alternative
Xtalks
Tuesday, May 30, 2023 - 10:05am
tags:
Medtech, ECG, ECG patches, nanocullulose, sustainability
China overtakes US in contributions to nature and science journals
The Guardian, UK
Tuesday, May 30, 2023 - 10:02am
tags:
China, R&D, academic research
Walgreens cutting 10% of corporate workforce, including in Deerfield and Chicago
Chicago Sun Times
Tuesday, May 30, 2023 - 9:58am
tags:
Walgreens, layoffs, opioids, legal

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

The Drug Discount Ecosystem’s “Mission Critical”
Drug Channels
Fakin' It the Modern Way
In the Pipeline
Reduction of Tau
In the Pipeline
Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels
AI and the Hard Stuff
In the Pipeline
Break Out the Purple Carrots
In the Pipeline
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
Give Me Those Hard, Hard Numbers
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information